Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Celldex Therapeutics, Inc. CLDX |
Ikarian Capital LLC | 1,364,990 3.500% |
-227,449 (-14.28%) |
Filing History |
| 2021-02-12 4:32 pm Sale |
2020-12-31 | 13G | Strongbridge Biopharma plc SBBP |
Ikarian Capital LLC | 2,440,028 3.600% |
-802,759 (-24.76%) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | KINETA INC KANT |
Ikarian Capital LLC | 132,514 1.300% |
132,514 (New Position) |
Filing History |
| 2021-02-12 4:31 pm Sale |
2020-12-31 | 13G | Verastem, Inc. VSTM |
Ikarian Capital LLC | 187,883 1.300% |
-233,107 (-55.37%) |
Filing History |
| 2021-02-12 4:31 pm Purchase |
2020-12-31 | 13G | Protara Therapeutics, Inc. TARA |
Ikarian Capital LLC | 649,542 5.800% |
649,542 (New Position) |
Filing History |
| 2021-01-11 5:25 pm Purchase |
2020-08-03 | 13G | Milestone Pharmaceuticals Inc. MIST |
Ikarian Capital LLC | 1,836,545 6.200% |
1,836,545 (New Position) |
Filing History |
| 2021-01-11 5:24 pm Purchase |
2020-11-24 | 13G | LifeSci Acquisition II Corp. LSAQ |
Ikarian Capital LLC | 512,450 6.400% |
512,450 (New Position) |
Filing History |
| 2021-01-08 9:59 pm Purchase |
2020-12-23 | 13G | Cyclacel Pharmaceuticals, Inc. CYCC |
Ikarian Capital LLC | 1,667 8.200% |
1,667 (New Position) |
Filing History |
| 2021-01-08 9:59 pm Purchase |
2020-09-18 | 13G | Aerpio Pharmaceuticals, Inc. ARPO |
Ikarian Capital LLC | 31,719 1.000% |
31,719 (New Position) |
Filing History |
| 2021-01-08 9:57 pm Purchase |
2020-12-24 | 13G | Bellicum Pharmaceuticals, Inc. BLCM |
Ikarian Capital LLC | 500,000 9.900% |
500,000 (New Position) |
Filing History |
| 2020-12-30 5:26 pm Purchase |
2020-12-29 | 13G | X4 Pharmaceuticals, Inc. XFOR |
Ikarian Capital LLC | 27,547 5.100% |
27,547 (New Position) |
Filing History |
| 2020-12-30 5:26 pm Purchase |
2020-12-15 | 13G | Lyra Therapeutics, Inc. LYRA |
Ikarian Capital LLC | 15,707 6.100% |
15,707 (New Position) |
Filing History |
| 2020-11-17 9:43 pm Purchase |
2020-11-17 | 13G | PROTEOSTASIS THERAPEUTICS INC PTI |
Ikarian Capital LLC | 2,650,347 5.100% |
2,650,347 (New Position) |
Filing History |
| 2020-09-14 5:00 pm Purchase |
2020-09-01 | 13G | TRACON Pharmaceuticals, Inc. TCON |
Ikarian Capital LLC | 108,127 16.400% |
108,127 (New Position) |
Filing History |